Tocilizumab is useful for coronavirus disease 2019 patients: the key point is timing

4-26-2022: At the start of the pandemic, Turkey chose hydroxychloroquine, azithromycin, lopinavir/ritonavir, and oseltamivir instead of favipiravir for early COVID-19. Today, Turkey donated vaccines and favipiravir to Turkmenistan https://t.co/yDll10RXQV

3-2022: Turkey has 8 of the world's 237 pro-Actemra COVID-19 studies (Celik, Ekinci, Eşkazan, Kaya, Keske, Küçük, Ozkarakas, Uysal), 0 of the world's 53 pro-Actemra meta-analyses. Muhammet Gülhan is now Turkey's 9th, world's 238th https://t.co/yDll10zOCN